Read the latest review of new developments in understanding and treating PSP, in this article published in Advances in Clincial Neuroscience and Rehabilitation

What's New In Progressive Supranuclear Palsy

Timothy Rittman is a Clinical Research Fellow in Cambridge and holds an MRC Clinical Research Training Fellowship. He trained in Nottingham and has worked in Lincoln, Norwich and London before arriving in Cambridge. He is interested in linking clinical features with pathological changes in neurodegenerative disorders, reflected in his current work developing functional connectivity disease biomarkers in tauopathies, with a focus on Progressive Supranuclear Palsy and Corticobasal Degeneration.

James Rowe is a Wellcome Trust Senior Research Fellow in Clinical Science and Reader in Cognitive Neurology at the University of Cambridge. He is a consultant neurologist at Addenbrooke's Hospital with specialist clinics for Progressive Supranuclear Palsy, Corticobasal Degeneration and Frontotemporal Dementia. His research interests include understanding and restoring cognitive function in neurodegenerative disease, using brain imaging with network modelling and psychopharmacology.